BioPharm International Editors


Biden Administration Invests in Antiviral Medicines

The US government will invest $3 billion from the American Rescue Plan into a COVID-19 antiviral development strategy.

GSK and iTeos Therapeutics Enter mAb Collaboration

GlaxoSmithKline and iTeos Therapeutics enter into a development and commercialization collaboration worth up to $2.08 billion for a new therapeutic anti-cancer mAb candidate.

PHE Analysis Demonstrates Efficacy of COVID Vaccines Against Delta Variant

Recent analysis has shown that two doses of COVID-19 vaccines are highly effective against hospitalization as a result of infection with the Delta variant of COVID-19.

Survey Reveals Attitudes of Public Toward Rare Diseases and Medicines Access

BIA has published a report presenting the findings of a survey on the public attitudes toward equal access to medicines for those living with rare diseases.